Julia Mayerle - Biography#

I received my medical training at the Semmelweis University in Budapest (Hungary) as well as the Julius Maximilians University Würzburg and the Westfalian-Wilhelms-University Münster. In 2001 I graduated from medical school and I defended my medical thesis with summa cum laude, was awarded by the medical faculty for the best medical thesis and I also received the award for the best thesis defended at the Westfalian Wilhelms-University in 2003. I received my medical training at the university hospital Münster, the university hospital Greifswald and the Royal Infirmary Glasgow. I was appointed assistant professor in 2007, associate professor and vice chair of the department of Mecine A at the University of Greifswald in 2011 and promoted to full Professor of gastroenterology and hepatology and chair of the department of medicine II at LMU Munich in 2016. I am board certified in internal medicine, gastroenterology and hepatology as well as endocrinology an diabetology. I have strong focus in interventional endoscopy.

As a gastroenterologist I mostly see patients with pancreatic disorders ranging from pancreatitis to cancer and as a researcher I was trained to participate in basic science projects as well as clinical projects ranging from randomized clinical trials to interventional endoscopy. During my training I repeatedly switched between work at the bedside and bench and spent time in laboratories focusing on pancreatic cancer (at Berne and UCL Irvine), cell biology (UCLA), and interventional endoscopy (Lister fellow, Glasgow). My research interest parallels the diseases of my patients and my laboratory has focused on the pathogenesis, genetics, and cell biology of pancreatitis and pancreatic cancer. Most of our projects are by design translational. The benefits of serving as a department chair at the University of Munich, whose medical school internationally top ranked, include the opportunity to transfer experimental research results directly into multicentre clinical trials (e.g. the META-PAC trial or MagPEP Trial NCT00142233). The principal focus of my grants, as well as my personal interest and expertise, involve the immunological response in pancreatitis and the role of early detection and treatment resistance in pancreatic cancer.

Imprint Privacy policy « This page (revision-3) was last changed on Wednesday, 20. July 2022, 17:46 by System
  • operated by